Abbas E Kitabchi
Overview
Explore the profile of Abbas E Kitabchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
6283
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lewis C, Bantle J, Bertoni A, Blackburn G, Brancati F, Bray G, et al.
Obesity (Silver Spring)
. 2020 Jan;
28(2):247-258.
PMID: 31898874
Objective: To examine the effects of an intensive lifestyle intervention (ILI) on cardiovascular disease (CVD), the Action for Health in Diabetes (Look AHEAD) trial randomized 5,145 participants with type 2...
2.
Stentz F, Brewer A, Wan J, Garber C, Daniels B, Sands C, et al.
BMJ Open Diabetes Res Care
. 2016 Nov;
4(1):e000258.
PMID: 27843552
Objective: Remission of pre-diabetes to normal is an important health concern which has had little success in the past. This study objective was to determine the effect on remission of...
3.
Espinoza S, Wang C, Tripathy D, Clement S, Schwenke D, Banerji M, et al.
Age (Dordr)
. 2016 Sep;
38(5-6):485-493.
PMID: 27585671
To determine the efficacy of pioglitazone to prevent type 2 diabetes in older compared to younger adults with pre-diabetes. Six hundred two participants with impaired glucose tolerance (IGT) were randomized...
4.
Tripathy D, Schwenke D, Banerji M, Bray G, Buchanan T, Clement S, et al.
J Clin Endocrinol Metab
. 2016 Mar;
101(5):2056-62.
PMID: 26982008
Context: Thiazolidinediones have proven efficacy in preventing diabetes in high-risk individuals. However, the effect of thiazolidinediones on glucose tolerance after cessation of therapy is unclear. Objective: To examine the effect...
5.
Nyenwe E, Kitabchi A
Metabolism
. 2016 Mar;
65(4):507-21.
PMID: 26975543
The prognosis of diabetic ketoacidosis has undergone incredibly remarkable evolution since the discovery of insulin nearly a century ago. The incidence and economic burden of diabetic ketoacidosis have continued to...
6.
Tripathy D, Cobb J, Gall W, Adam K, George T, Schwenke D, et al.
J Clin Endocrinol Metab
. 2015 Jan;
100(5):1855-62.
PMID: 25603459
Objective: The objective was to test the clinical utility of Quantose M(Q) to monitor changes in insulin sensitivity after pioglitazone therapy in prediabetic subjects. Quantose M(Q) is derived from fasting...
7.
Espeland M, Glick H, Bertoni A, Brancati F, Bray G, Clark J, et al.
Diabetes Care
. 2014 Aug;
37(9):2548-56.
PMID: 25147253
Objective: To assess the relative impact of an intensive lifestyle intervention (ILI) on use and costs of health care within the Look AHEAD trial. Research Design And Methods: A total...
8.
Steinberg H, Jacovino C, Kitabchi A
Curr Diab Rep
. 2014 May;
14(7):500.
PMID: 24863635
Look AHEAD is the only long-term study in a large cohort of subjects with type 2 diabetes that assessed the effect of intensive lifestyle, predominantly diet and exercise, on a...
9.
Goldberg R, Temprosa M, Mather K, Orchard T, Kitabchi A, Watson K
Diabetes Care
. 2014 May;
37(8):2253-60.
PMID: 24824548
Objective: We evaluate whether lifestyle and metformin interventions used to prevent diabetes have durable effects on markers of inflammation and coagulation and whether the effects are influenced by the development...
10.
Unick J, Hogan P, Neiberg R, Cheskin L, Dutton G, Evans-Hudnall G, et al.
Obesity (Silver Spring)
. 2014 Apr;
22(7):1608-16.
PMID: 24771618
Objective: Weight losses in lifestyle interventions are variable, yet prediction of long-term success is difficult. The utility of using various weight loss thresholds in the first 2 months of treatment...